Equal sensitivity of early and late scans after injection of FDG for the detection of Alzheimer pattern: an analysis of 3D PET data from J-ADNI, a multi-center study
Takeshi Iwatsubo(National Center of Neurology and Psychiatry), Michio Senda(Kyoto University), Takashi Kato(Showa University), Yoko Makishi(Foundation for Biomedical Research and Innovation), Ryuichi Takahashi(Hirosaki University), Kenji Ishii(Tokyo Metropolitan Institute of Gerontology), Kazunari Ishii(Hyogo Brain and Heart Center), Kengo Ito(National Center for Geriatrics and Gerontology), Yasuhiko Ikari(Japan Association for Development of Community Medicine), Tomoyuki Nishio(Kindai University Hospital)
Cited by 18
Related Papers
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|7.1k
Lecanemab in Early Alzheimer’s Disease
|New England Journal of Medicine|2022|5k
Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature
|Journal of Neuropathology & Experimental Neurology|2012|2.1k
High performance plasma amyloid-β biomarkers for Alzheimer’s disease
|Nature|2018|1.7k
Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's Disease
|The Journal of Prevention of Alzheimer s Disease|2022|1.3k